Stories

Prime Earns 2021 Top Workplaces USA Award

Award exhibits employee engagement

January 28, 2021
Prime was recently recognized with the 2021 Top Workplaces USA award. The award shines a national spotlight on companies that are great places to work.

This award encompasses Prime’s competitive benefits, community involvement and workplace culture. It also comes after Prime was recognized as a 2020 Star Tribune Top 150 Workplace, which also signifies a positive culture.

More than 1,100 companies nationwide participated in the Top Workplaces USA survey, which compiles employee feedback. The survey uses 15 culture drivers to predict high performance and an excellent culture.

“Even after a difficult year, it’s reassuring to know that employees feel strongly connected to their work,” said Erin Feigal, chief human resources officer. “I thank all of our employees who make Prime a great place to work every day in support of our health plan clients and members.”

About Prime Therapeutics

Prime Therapeutics LLC (Prime) is a diversified pharmacy solutions organization serving health plans, employers and government programs. Prime is collectively owned by 19 Blue Cross and Blue Shield Plans, subsidiaries or affiliates of those plans. Magellan Rx Management LLC, a Prime Therapeutics LLC Company, is a pioneer in specialty and medical drug management and a leader in serving public sector state government programs. Together Prime and Magellan Rx provide a wide range of clients with solutions that bridge the distance between medical and pharmacy management. For more information visit primetherapeutics.com and magellanrx.com or follow us on X (Twitter) at @Prime_PBM and @Magellan_Rx.

Related news

Stories

July 22, 2024

Introducing the latest issue of our medical and pharmacy benefit management report

The summer 2024 issue of the Magellan Rx Report provides insights on the industry’s most groundbreaking managed care solutions in some of the most complex areas of health care

Read More

Stories

July 18, 2024

Specialty drug trend forecasted to drop for employer groups, clinical experts say

Introduction of Humira® and Stelara® biosimilars contribute to continued decline in the autoimmune – anti-inflammatory trend

Read More

Stories

July 16, 2024

Prime/Magellan Rx earns top score on the Disability Equality Index

For the second consecutive year, Prime Therapeutics/Magellan Rx Management received a score of 100 on the Disability Equality Index®, which benchmarks disability workplace inclusion

Read More
View all news